Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jul 15, 2024; 16(7): 3082-3096
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3082
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3082
Figure 4 Genetic and epigenetic alterations of BCAR3 in hepatocellular carcinoma patients from The Cancer Genome Altas dataset.
A: Genetic features of BCAR3, including, including mutation, structural variant, amplification, deep deletion and multiple alteration, in different tumors of The Cancer Genome Altas analyzed by cBioPortal; B: Mutation site of BCAR3 in hepatocellular carcinoma (HCC); C: The mutation rate of BCAR3 in HCC.
- Citation: Shi HQ, Huang S, Ma XY, Tan ZJ, Luo R, Luo B, Zhang W, Shi L, Zhong XL, Lü MH, Chen X, Tang XW. BCAR3 and BCAR3-related competing endogenous RNA expression in hepatocellular carcinoma and their prognostic value. World J Gastrointest Oncol 2024; 16(7): 3082-3096
- URL: https://www.wjgnet.com/1948-5204/full/v16/i7/3082.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i7.3082